286 related articles for article (PubMed ID: 19899765)
1. Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.
Jullien N; Makritis A; Georgiadis D; Beau F; Yiotakis A; Dive V
J Med Chem; 2010 Jan; 53(1):208-20. PubMed ID: 19899765
[TBL] [Abstract][Full Text] [Related]
2. Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.
Daull P; Benrezzak O; Arsenault D; Pheng LH; Blouin A; Cayer J; Beaudoin M; Belleville K; Sirois P; Nantel F; Jeng AY; Battistini B
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1606-13. PubMed ID: 16364833
[TBL] [Abstract][Full Text] [Related]
3. Benzofused macrocyclic lactams as triple inhibitors of endothelin-converting enzyme, neutral endopeptidase 24.11, and angiotensin-converting enzyme.
Ksander GM; Savage P; Trapani AJ; Balwierczak JL; Jeng AY
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S71-3. PubMed ID: 9595404
[TBL] [Abstract][Full Text] [Related]
4. Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide.
Akif M; Schwager SL; Anthony CS; Czarny B; Beau F; Dive V; Sturrock ED; Acharya KR
Biochem J; 2011 May; 436(1):53-9. PubMed ID: 21352096
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
[TBL] [Abstract][Full Text] [Related]
6. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
[TBL] [Abstract][Full Text] [Related]
7. Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.
Daull P; Blouin A; Sirois P; Nantel F; Jeng AY; Battistini B
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S398-401. PubMed ID: 15838331
[TBL] [Abstract][Full Text] [Related]
8. [Study of substrate specificity of a new peptide substrate of endothelin converting enzyme].
Gureeva TA; Kugaevskaia EV; Pozdnev VF; Prozorovskiĭ VN; Eliseeva IuE; Solov'eva NI
Biomed Khim; 2007; 53(2):172-80. PubMed ID: 17639718
[TBL] [Abstract][Full Text] [Related]
9. CGS 35601, a triple inhibitor of angiotensin converting enzyme, neutral endopeptidase and endothelin converting enzyme.
Battistini B; Daull P; Jeng AY
Cardiovasc Drug Rev; 2005; 23(4):317-30. PubMed ID: 16614731
[TBL] [Abstract][Full Text] [Related]
10. Effects of milk casein derived tripeptides on endothelial enzymes in vitro; a study with synthetic tripeptides.
Siltari A; Kivimäki AS; Ehlers PI; Korpela R; Vapaatalo H
Arzneimittelforschung; 2012 Oct; 62(10):477-81. PubMed ID: 22918858
[TBL] [Abstract][Full Text] [Related]
11. In vivo properties of thiol inhibitors of the three vasopeptidases NEP, ACE and ECE are improved by introduction of a 7-azatryptophan in P2' position.
Inguimbert N; Poras H; Dhotel H; Beslot F; Scalbert E; Bennejean C; Renard P; Fournié-Zaluski MC; Roques BP
J Pept Res; 2004 Feb; 63(2):99-107. PubMed ID: 15009531
[TBL] [Abstract][Full Text] [Related]
12. Targeting ACE and ECE with dual acting inhibitors.
Hanessian S; Guesné S; Riber L; Marin J; Benoist A; Mennecier P; Rupin A; Verbeuren TJ; De Nanteuil G
Bioorg Med Chem Lett; 2008 Feb; 18(3):1058-62. PubMed ID: 18160283
[TBL] [Abstract][Full Text] [Related]
13. CGS 35601 and its orally active prodrug CGS 37808 as triple inhibitors of endothelin-converting enzyme-1, neutral endopeptidase 24.11, and angiotensin-converting enzyme.
Trapani AJ; Beil ME; Bruseo CW; Savage P; Firooznia F; Jeng AY
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S211-5. PubMed ID: 15838282
[TBL] [Abstract][Full Text] [Related]
14. Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats.
Emoto N; Raharjo SB; Isaka D; Masuda S; Adiarto S; Jeng AY; Yokoyama M
Hypertension; 2005 Jun; 45(6):1145-52. PubMed ID: 15897363
[TBL] [Abstract][Full Text] [Related]
15. N-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidases (NEP, ACE, ECE): In vitro and In vivo activities.
Inguimbert N; Poras H; Teffo F; Beslot F; Selkti M; Tomas A; Scalbert E; Bennejean C; Renard P; Fournié-Zaluski MC; Roques BP
Bioorg Med Chem Lett; 2002 Aug; 12(15):2001-5. PubMed ID: 12113828
[TBL] [Abstract][Full Text] [Related]
16. Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition.
Mellin V; Jeng AY; Monteil C; Renet S; Henry JP; Thuillez C; Mulder P
J Cardiovasc Pharmacol; 2005 Sep; 46(3):390-7. PubMed ID: 16116347
[TBL] [Abstract][Full Text] [Related]
17. Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats.
Battistini B; Ayach B; Molez S; Blouin A; Jeng AY
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():363S-366S. PubMed ID: 12193123
[TBL] [Abstract][Full Text] [Related]
18. Towards triple vasopeptidase inhibitors for the treatment of cardiovascular diseases.
Daull P; Jeng AY; Battistini B
J Cardiovasc Pharmacol; 2007 Sep; 50(3):247-56. PubMed ID: 17878751
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme.
Wallace EM; Moliterni JA; Moskal MA; Neubert AD; Marcopulos N; Stamford LB; Trapani AJ; Savage P; Chou M; Jeng AY
J Med Chem; 1998 Apr; 41(9):1513-23. PubMed ID: 9554884
[TBL] [Abstract][Full Text] [Related]
20. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
